Advances in Vision Research, Volume IV (Record no. 60502)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 06669nam a22005535i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-981-99-4436-1 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20251030112257.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240603s2024 si | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9789819944361 |
| -- | 978-981-99-4436-1 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-981-99-4436-1 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RE1-994 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJQ |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED063000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJQ |
| Source | thema |
| 245 10 - TITLE STATEMENT | |
| Title | Advances in Vision Research, Volume IV |
| Medium | [electronic resource] : |
| Remainder of title | From Basic to Translational Research — Developing Diagnostics and Therapeutics for Genetic Eye Diseases / |
| Statement of responsibility, etc. | edited by Gyan Prakash, Takeshi Iwata. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. 2024. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Singapore : |
| Name of producer, publisher, distributor, manufacturer | Springer Nature Singapore : |
| -- | Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2024. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XIX, 388 p. 102 illus., 96 illus. in color. |
| Other physical details | online resource. |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS | |
| File type | text file |
| Encoding format | |
| Source | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Essentials in Ophthalmology, |
| International Standard Serial Number | 2196-890X |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Part I Gene therapy for ocular genetic diseases -- Chapter 1 Gene therapy for neovascular age-related macular degeneration -- Chapter 2 Gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR -- Chapter 3 Optogenetic approaches to restore vision -- Chapter 4 Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis -- Chapter 5 Subretinal versus Intravitreal Delivery of AAV8 in Nonhuman Primates -- Chapter 6 Gene therapy for Leber Congenital Amaurosis caused by mutation in RPE65 -- Chapter 7 Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy -- Chapter 8 Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber’s Hereditary Optic Neuropathy -- Part II Gene editing as therapy for ocular disease -- Chapter 9 Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9 -- Chapter 10 Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 in Mouse and Macaque -- Chapter 11 In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in Mouse Model of X-Linked Retinitis Pigmentosa -- Chapter 12 Gene Expression and Editing in Mammalian Retinal Ganglion Cells -- Chapter 13 AAV-mediated mutation replacement genome editing in photoreceptors restores vision in mice -- Chapter 14 Gene Editing Preserves Visual Functions in a Mouse Model of Retinal Degeneration -- Chapter 15 Genome Editing as Treatment for Autosomal Dominant Retinitis Pigmentosa -- Chapter 16 CRISPR/Cas base editors to target the AMD high-risk variant -- Part III Cell therapy for ocular genetic diseases -- Chapter 17 Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration -- Chapter 18 Transplantation Retinal Sheet Differentiated from Patient iPS Cells with Inherited Retinitis Pigmentosa -- Chapter 19 Clinical study of an ES cell-derived retinal pigment epithelium patch in age-related macular degeneration -- Chapter 20 Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients -- Chapter 21 Preclinical safety studies of human embryonic stem cell-derived retinal pigment epithelial cells for the treatment of age-related macular degeneration -- Chapter 22 Corneal endothelial cell derivation methods from ES and iPS cells -- Chapter 23 Gene editing approach to restore vision loss in Leber Congenital Amaurosis type 10 -- Chapter 24 Inhibition of Optineurin – TANK Binding Kinase 1 interaction to suppress inherited normal tension glaucoma -- Chapter 25 A 3D Printed Self-Sustainable Cell-Encapsulation Drug Delivery Device for Periocular Transplant-Based Treatment of Retinal Degenerative Diseases -- Chapter 26 Complement inhibition as therapy for retinal diseases -- Chapter 27 Neuroprotective Therapy for Retinal Ganglion Cell Degeneration -- Chapter 28 Artificial intelligence in retina -- Chapter 29 Prediction of AI for Treatment Potential for Macular Cone Vision in Leber Congenital Amaurosis -- Chapter 30 Artificial Intelligence for Evaluation of Macular Degeneration and Suspected Glaucoma -- Chapter 31 Artificial Intelligence Classification of Central Visual Field Patterns in Glaucoma -- Chapter 32 Artificial intelligence and deep learning in ophthalmology. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This fourth volume in the series Advances in Vision Research describes importance advancements in basics to translational research, including new therapeutics for genetic eye diseases. Recent US FDA approval of the first gene therapy for an inherited retinal disease, due to a mutation in the RPE65 gene, has led to an upsurge in translational eye research. The coverage in this volume includes corneal diseases, myopia, cataract, glaucoma, inherited retinal diseases, inherited optic neuropathy, and other genetic eye diseases. New developments such as the application of artificial intelligence in translational eye research are also discussed. All chapters are written by leading researchers working on eye genetics from the fields of Human Genetics, Ophthalmology, Molecular Biology, Biochemistry, Sensory Sciences, and Clinical Research. Advances in Vision Research, Volume IV will be a major resource for all researchers, clinicians, clinical researchers, and allied eye health professionals with an interest in eye diseases around the globe. The first two volumes in the series described the state of the art in genetic eye research in Asia and the Pacific while the third focused on progress in Europe and the United States. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 72072 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 64976 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 67435 |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 72072 |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 64976 |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 67439 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Prakash, Gyan. |
| Relator term | editor. |
| Relator code | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 9 (RLIN) | 78221 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Iwata, Takeshi. |
| Relator term | editor. |
| Authority record control number | (orcid)0000-0003-1447-0081 |
| -- | https://orcid.org/0000-0003-1447-0081 |
| Relator code | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 9 (RLIN) | 78222 |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer Nature eBook |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9789819944354 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9789819944378 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9789819944385 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Essentials in Ophthalmology, |
| International Standard Serial Number | 2196-890X |
| 9 (RLIN) | 78223 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/978-981-99-4436-1">https://doi.org/10.1007/978-981-99-4436-1</a> |
| 912 ## - | |
| -- | ZDB-2-SME |
| 912 ## - | |
| -- | ZDB-2-SXM |
No items available.